HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedione

structure given in first source
Also Known As:
MHAQ
Networked: 94 relevant articles (7 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kvien, T K: 5 articles (01/2015 - 11/2005)
2. Kremer, Joel M: 4 articles (06/2021 - 10/2008)
3. Uhlig, T: 4 articles (01/2015 - 11/2005)
4. Mowinckel, P: 4 articles (01/2009 - 11/2005)
5. Tohma, Shigeto: 3 articles (09/2022 - 07/2016)
6. Maheu, Emmanuel: 3 articles (06/2022 - 12/2018)
7. Harrold, Leslie R: 3 articles (06/2021 - 09/2017)
8. Gossec, Laure: 3 articles (12/2020 - 04/2016)
9. Greenberg, Jeffrey D: 3 articles (12/2017 - 08/2010)
10. Matsui, Toshihiro: 2 articles (09/2022 - 04/2018)

Related Diseases

1. Pain (Aches)
2. Fatigue
3. Rheumatoid Arthritis
4. Restless Legs Syndrome (Restless Legs)
5. Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)

Related Drugs and Biologics

1. ametantrone (HAQ)
2. tocilizumab (atlizumab)
3. 4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
4. Antirheumatic Agents (DMARD)
5. C-Reactive Protein
6. Rheumatoid Factor
7. Prostaglandins A
8. Methotrexate (Mexate)
9. Abatacept (Orencia)
10. Leukocyte L1 Antigen Complex (Calgranulin)

Related Therapies and Procedures

1. Therapeutics
2. Activities of Daily Living (ADL)
3. Complementary Therapies (Alternative Medicine)